These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 415009)

  • 21. In vitro lymphocyte response to purified protein derivative, BCG and Mycobacterium leprae in a population not exposed to leprosy.
    Closs O
    Infect Immun; 1975 Jun; 11(6):1163-9. PubMed ID: 1095479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strain variations in the murine cellular immune response to the phenolic glycolipid I antigen of Mycobacterium leprae.
    Koster FT; Teuscher C; Matzner P; Umland E; Yanagihara D; Brennan PJ; Tung KS
    Infect Immun; 1986 Feb; 51(2):495-500. PubMed ID: 3510979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-lasting T-cell reactivity to Mycobacterium leprae antigens in human volunteers vaccinated with killed M. leprae.
    Mustafa AS; Oftung F
    Vaccine; 1993; 11(11):1108-12. PubMed ID: 7504379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Mycobacterium leprae immunogenicity via adoptive transfer studies.
    Graham L; Navalkar RG
    Infect Immun; 1984 Jan; 43(1):79-83. PubMed ID: 6360910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization of mice with Mycobacterium leprae/Mycobacterium bovis BCG admixtures: modulation of the acquired response to BCG.
    Orme IM
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):293-8. PubMed ID: 3298475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction by killed Listeria monocytogenes of effector T cells mediating delayed-type hypersensitivity but not protection in mice.
    Koga T; Mitsuyama M; Handa T; Yayama T; Muramori K; Nomoto K
    Immunology; 1987 Oct; 62(2):241-8. PubMed ID: 2445666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitization or tolerance to Mycobacterium leprae antigen by route of injection.
    Shepard CC; Walker LL; Van Landingham RM; Ye SZ
    Infect Immun; 1982 Nov; 38(2):673-80. PubMed ID: 6754621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.
    Kaplan G; Sampaio EP; Walsh GP; Burkhardt RA; Fajardo TT; Guido LS; de Miranda Machado A; Cellona RV; Abalos RM; Sarno EN
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6269-73. PubMed ID: 2668961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):265-73. PubMed ID: 3045224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients.
    Kaleab B; Ottenoff T; Converse P; Halapi E; Tadesse G; Rottenberg M; Kiessling R
    Eur J Immunol; 1990 Dec; 20(12):2651-9. PubMed ID: 2269329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of synthetic peptides corresponding to sequences of Mycobacterium leprae proteins to study delayed-type hypersensitivity response in sensitized guinea pigs.
    Estrada IC; Gutiérrez MC; Esparza J; Quesada-Pascual F; Estrada-Parra S; Possani LD
    Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):18-27. PubMed ID: 1602190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of a cell-mediated reaction to the purified protein derivative of tuberculin in the disposal of Mycobacterium leprae from human skin.
    Kaplan G; Sheftel G; Job CK; Mathur NK; Nath I; Cohn ZA
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5210-4. PubMed ID: 2969108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of delayed-type hypersensitivity by ICRC anti-leprosy vaccine and the adoptive transfer of cell-mediated immunity in mice.
    Jeevan A; Bapat CV
    Indian J Lepr; 1984; 56(4):754-63. PubMed ID: 6398339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nerve damage following intraneural injection of Mycobacterium leprae into rabbits pre-sensitized to mycobacteria.
    Mshana RN; Humber DP; Harboe M; Belehu A
    Clin Exp Immunol; 1983 May; 52(2):441-8. PubMed ID: 6345041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that the Mitsuda reaction to Mycobacterium leprae can be mediated by lymphocytes responsive to Mycobacterium tuberculosis.
    Roberts PP; Dockrell HM; McAdam KP
    Clin Exp Immunol; 1988 Jun; 72(3):390-3. PubMed ID: 2458870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homologs of Mycobacterium leprae 18-kilodalton and Mycobacterium tuberculosis 19-kilodalton antigens in other mycobacteria.
    Booth RJ; Williams DL; Moudgil KD; Noonan LC; Grandison PM; McKee JJ; Prestidge RL; Watson JD
    Infect Immun; 1993 Apr; 61(4):1509-15. PubMed ID: 8454357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of delayed-type hypersensitivity in human volunteers immunized with a candidate leprosy vaccine consisting of killed Mycobacterium leprae.
    Gill HK; Mustafa AS; Godal T
    Bull World Health Organ; 1986; 64(1):121-6. PubMed ID: 3524883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic control of delayed type hypersensitivity to Mycobacterium leprae antigen.
    Ishii N; Nakajima H; Aoki I; Shimoda N; Mori T
    Nihon Rai Gakkai Zasshi; 1990; 59(3-4):154-61. PubMed ID: 2133466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.